315 件の文書 found
Original Strem safety data sheet for Gadolinium(III) trifluoromethanesulfonate, min. 98% (Gadolinium triflate). 原本PDF retained without modification. 情報源 collected on 2026-09-13.
RESDSが収集し、発行元の原本PDFをそのまま保持しています。 Original manufacturer safety data sheet for Gadolinium, AAS 標準液, Specpure®, Gd 1000µg/ml. Product number: ALFAA88065. 原本改訂日: 04-Aug-2026. 公開日 under the file-level authorization confirmed by the user for the frozen 1,125-file manifest.
Original ProChem safety data sheet for Gadolinium, Chips. 原本PDF retained without modification. 情報源 collected on 2026-09-13.
Original Sigma-Aldrich safety data sheet for Gadolinium, chips, 99.9% trace rare earth metals basis. 原本PDF retained without modification. 情報源 collected on 2026-09-13.
RESDSが収集し、発行元の原本PDFをそのまま保持しています。 Original manufacturer safety data sheet for Gadolinium, plasma 標準液, Specpure®, Gd 10,000µg/ml. Product number: ALFAA14373. 原本改訂日: 04-Aug-2026. 公開日 under the file-level authorization confirmed by the user for the frozen 1,125-file manifest.
RESDSが収集し、発行元の原本PDFをそのまま保持しています。 Original manufacturer safety data sheet for Gadolinium, plasma 標準液, Specpure®, Gd 1000µg/ml. Product number: ALFAA13829. 原本改訂日: 04-Aug-2026. 公開日 under the file-level authorization confirmed by the user for the frozen 1,125-file manifest.
Original ProChem safety data sheet for Gadolinium, Powder. 原本PDF retained without modification. 情報源 collected on 2026-09-13.
Original Indagoo safety data sheet for Gadopentetate dimeglumine. 原本PDF retained without modification. 情報源 collected on 2026-09-13.
Original USP safety data sheet for Gadoterate meglumine - USP reference standard. 原本PDF retained without modification. 情報源 collected on 2026-09-13.
Original Cleanchem safety data sheet for Gadoterate Meglumine. 原本PDF retained without modification. 情報源 collected on 2026-09-13.
Original Cleanchem safety data sheet for Gadoteridol Impurity 6. 原本PDF retained without modification. 情報源 collected on 2026-09-13.
Original APExBIO safety data sheet for Gadoteridol. 原本PDF retained without modification. 情報源 collected on 2026-09-13.
Original Cayman Chemical safety data sheet for Gadoteridol. 原本PDF retained without modification. 情報源 collected on 2026-09-13.
Original MedChemExpress safety data sheet for Gadoteridol. 原本PDF retained without modification. 情報源 collected on 2026-09-13.
Original Sigma-Aldrich safety data sheet for Gadoteridol. 原本PDF retained without modification. 情報源 collected on 2026-09-13.
Original Ambeed safety data sheet for Gadoxetate disodium. 原本PDF retained without modification. 情報源 collected on 2026-09-13.
Original Ambeed safety data sheet for Gadoxetate disodium. 原本PDF retained without modification. 情報源 collected on 2026-09-13.
RESDSが収集し、発行元の原本PDFをそのまま保持しています。 GADS-1 gadolinium isotopic CRM for laboratory use. SDS Section 3 lists nitric acid 2.0% (CAS 7697-37-2) and gadolinium oxide 0.1% (CAS 12064-62-9). 改訂版 2019年8月26日, version 1.0. 情報源: National Research Council Canada. Licensed under the 開く Government Licence – Canada.
RESDSが収集し、発行元の原本PDFをそのまま保持しています。 GADS-1, matériau de référence certifié isotopique du gadolinium pour utilisation en laboratoire. La section 3 de la FDS indique 2,0 % d'acide nitrique (CAS 7697-37-2) et 0,1 % de trioxyde de digadolinium (CAS 12064-62-9). Révision du 26 août 2019, version 1,0. 情報源 : Conseil national de recherches Canada. Licence du gouvernement ouvert – Canada.
RESDSが収集し、発行元の原本PDFをそのまま保持しています。 Original manufacturer safety data sheet for Iron yttrium oxide. Product number: ALFAA39488. 原本改訂日: 27-Jul-2026. 公開日 under the file-level authorization confirmed by the user for the frozen 1,125-file manifest.
RESDSが収集し、発行元の原本PDFをそのまま保持しています。 Radioactive monazite reference material containing cerium, lanthanum, praseodymium, neodymium and optional yttrium phosphates, with thorium and uranium phosphates and quartz listed in Section 3. Original 17-page SDS revised 2020年6月24日. U.S. Department of Energy government information; republished with acknowledgement under DOE web policy: https://www.energy.gov/web-policies
RESDSが収集し、発行元の原本PDFをそのまま保持しています。 Earlier official revision of the radioactive monazite reference-material SDS. Section 3 lists cerium, lanthanum, praseodymium, neodymium and optional yttrium phosphates, plus thorium and uranium phosphates and quartz. Created 2011年7月29日 and revised 2014年10月8日. U.S. Department of Energy government information; republished with acknowledgement under DOE web policy: https://www.energy.gov/web-policies
RESDSが収集し、発行元の原本PDFをそのまま保持しています。 Mineral sands concentrate used as raw material for rare-earth compounds. Section 3 is a multi-mineral mixture; CAS numbers and composition are retained only as stated by the original SDS. 改訂版 2022年10月4日. 情報源: RZ Resources Ltd. Publication authorization confirmed by the RESDS site owner on 2026年9月14日.
Original Bracco safety data sheet for MultiHance (CAN). 原本PDF retained without modification. 情報源 collected on 2026-09-13.